β-淀粉样蛋白PET分层的痴呆患者与健康对照的定量磁化率成像——一项混合PET/MRI研究
本研究回顾性分析11例健康对照、16例Aβ阳性AD患者和10例Aβ阴性非AD患者的[11C]PiB PET/MRI数据,用定量磁化率成像(QSM)评估脑铁沉积。AD患者壳核QSM值高于健康对照,非AD患者尾状核QSM值低于健康对照;AD患者全脑Aβ负荷与壳核QSM值显著相关。作者认为AD与非AD患者可能存在不同的脑铁病理,QSM或可检测,并鼓励在明确界定的队列中进一步研究。
要点
- AD患者壳核QSM值高于健康对照(0.049±0.033 vs. 0.002±0.031,p=0.006)。
- 非AD患者尾状核QSM值低于健康对照(0.003±0.027 vs. 0.051±0.039,p=0.006)。
- AD患者全脑Aβ负荷与壳核QSM值显著相关(ρ=-0.574,p=0.020)。
核心结论
- AD与非AD患者可能表现出不同的脑铁病理,QSM MRI或可检测,并可能与神经变性相关。
- 数据鼓励在明确界定的患者队列中进一步研究,以明确QSM/磁化率在神经变性疾病病程中的价值及其作为诊断生物标志物的潜力。
研究设计与样本
- 回顾性分析11例健康对照、16例AD患者和10例非AD患者的[11C]PiB PET/MRI数据。
- 使用3T PET/MR扫描仪采集QSM作为铁敏感MRI信号,全脑Aβ负荷由复合[11C]PiB SUV比值确定。
关键影像表现/征象
- AD患者壳核QSM值高于健康对照(0.049±0.033 vs. 0.002±0.031;p=0.006)。
- 非AD患者尾状核QSM值低于健康对照(0.003±0.027 vs. 0.051±0.039;p=0.006)。
- 壳核QSM与MMSE评分呈接近显著的负相关趋势(ρ=-0.340,p=0.053)。
- AD患者全脑Aβ负荷与壳核QSM值呈显著负相关(ρ=-0.574,p=0.020)。
临床应用与阅片要点
- 作者认为AD与非AD患者可能表现出不同的脑铁病理,QSM MRI或可检测,并可能与神经变性相关。
- 作者鼓励在明确界定的患者队列中进一步研究,以明确QSM/磁化率在神经变性疾病病程中的价值及其作为诊断生物标志物的潜力。
局限性
- 原文为探索性研究。
- 作者在结论中鼓励在明确界定的患者队列中进一步研究,以明确QSM/磁化率的价值。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Post-mortem and in-vivo MRI data suggest an accumulation of iron in the brain of Alzheimer's disease (AD) patients. The majority of studies in clinically diagnosed AD patients found an increase of iron-sensitive MRI signals in the putamen. As the clinical diagnosis shows only a moderate sensitivity, Aβ-PET was used to further stratify patients with the clinical diagnosis of AD. Aim of this exploratory study was to examine whether Aβ-positive (AD) and Aβ-negative (non-AD) patients differ in their regional magnetic susceptibility compared to healthy controls (HCs) and whether regional susceptibility values correlate with mini mental state examination (MMSE) scores or global Aβ-load.
METHODS: We retrospectively analyzed [11C]PiB PET/MRI data of 11 HCs, 16 AD and 10 non-AD patients. We used quantitative susceptibility mapping (QSM) as iron-sensitive MRI signal measured at the 3 T PET/MR scanner. Global cerebral Aβ-load was determined by composite [11C]PiB SUV ratios.
RESULTS: Compared to HCs, AD patients showed higher QSM values in putamen (0.049 ± 0.033 vs. 0.002 ± 0.031; p = 0.006), while non-AD patients showed lower QSM values in caudate nucleus (0.003 ± 0.027 vs. 0.051 ± 0.039; p = 0.006). There was a trend towards a significant correlation between putaminal QSM and MMSE values (ρ=-0.340, p = 0.053). In AD patients, global Aβ-load and putaminal QSM values were significantly correlated (ρ=-0.574, p = 0.020).
CONCLUSIONS: These data indicate that AD and non-AD patients may show different cerebral iron pathologies which might be detectable by QSM MRI, and might be linked to neurodegeneration. Overall, the data encourage further investigations in well-defined patient cohorts to clarify the value of QSM/magnetic susceptibility in the course of neurodegenerative diseases and its potential as diagnostic biomarker.
引用
- Tiepolt S, Rullmann M, Jochimsen TH, et al. Quantitative susceptibility mapping in β-Amyloid PET-stratified patients with dementia and healthy controls - A hybrid PET/MRI study. Eur J Radiol. 2020. PMID: 32916411. doi:10.1016/j.ejrad.2020.109243
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。